Growing community of inventors

Jena, Germany

Niels Christoph Riedemann

Average Co-Inventor Count = 2.49

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 47

Niels Christoph RiedemannRenfeng Guo (11 patents)Niels Christoph RiedemannYan Li (3 patents)Niels Christoph RiedemannBeifen Shen (3 patents)Niels Christoph RiedemannYong Li (2 patents)Niels Christoph RiedemannLi Yan (0 patent)Niels Christoph RiedemannYan Li (1 patent)Niels Christoph RiedemannShen Beifen (0 patent)Niels Christoph RiedemannNiels Christoph Riedemann (11 patents)Renfeng GuoRenfeng Guo (14 patents)Yan LiYan Li (285 patents)Beifen ShenBeifen Shen (7 patents)Yong LiYong Li (2 patents)Li YanLi Yan (0 patent)Yan LiYan Li (14 patents)Shen BeifenShen Beifen (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Inflarx Gmbh (11 from 13 patents)


11 patents:

1. 12180274 - Treatment of pneumonia and ARDS with inhibitors of C5a and IL-6 activity

2. 11999698 - Fused piperidinyl bicyclic and related compounds as modulators of C5a receptor

3. 11890349 - Treatment of inflammatory diseases with inhibitors of C5A activity

4. 11464868 - Treatment of inflammatory diseases with inhibitors of C5A activity

5. 11149009 - Fused piperidinyl bicyclic and related compounds as modulators of C5A receptor

6. 10858421 - Inhibitors of C5A for the treatment of viral pneumonia

7. 10774136 - Anti-C5a binding moieties with high blocking activity

8. 10376595 - Treatment of inflammatory diseases with inhibitors of C5a activity

9. 10227397 - Inhibitors of C5a for the treatment of viral pneumonia

10. 9458233 - Anti-C5a binding moieties with high blocking activity

11. 8802096 - Anti-C5a binding antibodies with high block activity

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/11/2025
Loading…